Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Continuous Suture Technique for Aortic Valve Replacement: Technical Considerations and Controversies.

Stamou SC, Moeller EA, Nores MA.

Int J Angiol. 2019 Mar;28(1):64-68. doi: 10.1055/s-0038-1676967. Epub 2019 Jan 28.

PMID:
30880896
2.

Outcomes of Arthroscopic Posterior Shoulder Stabilization in the Beach-Chair Versus Lateral Decubitus Position: A Systematic Review.

Moeller EA, Houck DA, McCarty EC, Seidl AJ, Bravman JT, Vidal AF, Frank RM.

Orthop J Sports Med. 2019 Jan 24;7(1):2325967118822452. doi: 10.1177/2325967118822452. eCollection 2019 Jan. Review.

3.

Preoperative Hypoglycemia and Hyperglycemia Are Related to Postoperative Infection Rates in Implant-Based Breast Reconstruction.

Law TY, Moeller E, Hubbard ZS, Rosas S, Andreoni A, Chim HW.

J Surg Res. 2018 Dec;232:437-441. doi: 10.1016/j.jss.2018.06.068. Epub 2018 Jul 21.

PMID:
30463754
4.

Predicting outstanding results after anatomic total shoulder arthroplasty using percentage of maximal outcome improvement.

Berglund DD, Damodar D, Vakharia RM, Moeller EA, Giveans MR, Horn B, Mijic D, Levy JC.

J Shoulder Elbow Surg. 2019 Feb;28(2):349-356. doi: 10.1016/j.jse.2018.08.016. Epub 2018 Nov 5.

PMID:
30404717
5.

Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries.

Garland SM, Pitisuttithum P, Ngan HYS, Cho CH, Lee CY, Chen CA, Yang YC, Chu TY, Twu NF, Samakoses R, Takeuchi Y, Cheung TH, Kim SC, Huang LM, Kim BG, Kim YT, Kim KH, Song YS, Lalwani S, Kang JH, Sakamoto M, Ryu HS, Bhatla N, Yoshikawa H, Ellison MC, Han SR, Moeller E, Murata S, Ritter M, Sawata M, Shields C, Walia A, Perez G, Luxembourg A.

J Infect Dis. 2018 Jun 5;218(1):95-108. doi: 10.1093/infdis/jiy133.

6.

Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women.

Ruiz-Sternberg ÁM, Moreira ED Jr, Restrepo JA, Lazcano-Ponce E, Cabello R, Silva A, Andrade R, Revollo F, Uscanga S, Victoria A, Guevara AM, Luna J, Plata M, Dominguez CN, Fedrizzi E, Suarez E, Reina JC, Ellison MC, Moeller E, Ritter M, Shields C, Cashat M, Perez G, Luxembourg A.

Papillomavirus Res. 2018 Jun;5:63-74. doi: 10.1016/j.pvr.2017.12.004. Epub 2017 Dec 19.

7.

9-Valent human papillomavirus vaccine: a review of the clinical development program.

Luxembourg A, Moeller E.

Expert Rev Vaccines. 2017 Nov;16(11):1119-1139. doi: 10.1080/14760584.2017.1383158. Epub 2017 Oct 9. Review.

PMID:
28956458
8.

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.

Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, Mayrand MH, Ruiz-Sternberg AM, Stapleton JT, Wiley DJ, Ferenczy A, Kurman R, Ronnett BM, Stoler MH, Cuzick J, Garland SM, Kjaer SK, Bautista OM, Haupt R, Moeller E, Ritter M, Roberts CC, Shields C, Luxembourg A.

Lancet. 2017 Nov 11;390(10108):2143-2159. doi: 10.1016/S0140-6736(17)31821-4. Epub 2017 Sep 5.

PMID:
28886907
9.

Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials.

Petersen LK, Restrepo J, Moreira ED Jr, Iversen OE, Pitisuttithum P, Van Damme P, Joura EA, Olsson SE, Ferris D, Block S, Giuliano AR, Bosch X, Pils S, Cuzick J, Garland SM, Huh W, Kjaer SK, Bautista OM, Hyatt D, Maansson R, Moeller E, Qi H, Roberts C, Luxembourg A.

Papillomavirus Res. 2017 Jun;3:105-115. doi: 10.1016/j.pvr.2017.03.002. Epub 2017 Mar 16.

10.

Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials.

Moreira ED Jr, Block SL, Ferris D, Giuliano AR, Iversen OE, Joura EA, Kosalaraksa P, Schilling A, Van Damme P, Bornstein J, Bosch FX, Pils S, Cuzick J, Garland SM, Huh W, Kjaer SK, Qi H, Hyatt D, Martin J, Moeller E, Ritter M, Baudin M, Luxembourg A.

Pediatrics. 2016 Aug;138(2). pii: e20154387. doi: 10.1542/peds.2015-4387. Epub 2016 Jul 15.

11.

Immunogenicity and Safety of a 9-Valent HPV Vaccine.

Van Damme P, Olsson SE, Block S, Castellsague X, Gray GE, Herrera T, Huang LM, Kim DS, Pitisuttithum P, Chen J, Christiano S, Maansson R, Moeller E, Sun X, Vuocolo S, Luxembourg A.

Pediatrics. 2015 Jul;136(1):e28-39. doi: 10.1542/peds.2014-3745.

12.

Phase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine.

Luxembourg A, Moreira ED Jr, Samakoses R, Kim KH, Sun X, Maansson R, Moeller E, Christiano S, Chen J.

Hum Vaccin Immunother. 2015;11(6):1306-12. doi: 10.1080/21645515.2015.1009819.

13.

Phase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccine.

Luxembourg A, Brown D, Bouchard C, Giuliano AR, Iversen OE, Joura EA, Penny ME, Restrepo JA, Romaguera J, Maansson R, Moeller E, Ritter M, Chen J.

Hum Vaccin Immunother. 2015;11(6):1313-22. doi: 10.1080/21645515.2015.1012010.

14.

Design of a large outcome trial for a multivalent human papillomavirus L1 virus-like particle vaccine.

Luxembourg A, Bautista O, Moeller E, Ritter M, Chen J.

Contemp Clin Trials. 2015 May;42:18-25. doi: 10.1016/j.cct.2015.02.009. Epub 2015 Mar 3.

PMID:
25749310
15.

A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED Jr, Ngan Y, Petersen LK, Lazcano-Ponce E, Pitisuttithum P, Restrepo JA, Stuart G, Woelber L, Yang YC, Cuzick J, Garland SM, Huh W, Kjaer SK, Bautista OM, Chan IS, Chen J, Gesser R, Moeller E, Ritter M, Vuocolo S, Luxembourg A; Broad Spectrum HPV Vaccine Study.

N Engl J Med. 2015 Feb 19;372(8):711-23. doi: 10.1056/NEJMoa1405044.

16.

As time goes by: reasons and characteristics of prolonged episodes of mechanical restraint in forensic psychiatry.

Gildberg FA, Fristed P, Makransky G, Moeller EH, Nielsen LD, Bradley SK.

J Forensic Nurs. 2015 Jan-Mar;11(1):41-50. doi: 10.1097/JFN.0000000000000055.

PMID:
25622065
17.

Research into practice: postsecondary success in the Chicago Public Schools.

Johnson DW, Moeller E, Holsapple M.

New Dir Youth Dev. 2013 Winter;2013(140):31-53. doi: 10.1002/yd.20077.

PMID:
24474257
18.

Postoperative glaucoma in the Labrador Retriever: incidence, risk factors, and visual outcome following routine phacoemulsification.

Moeller E, Blocker T, Esson D, Madsen R.

Vet Ophthalmol. 2011 Nov;14(6):385-94. doi: 10.1111/j.1463-5224.2011.00896.x. Epub 2011 Apr 19.

PMID:
22050844
19.

Ionic strength-dependent denaturation of Thermomyces lanuginosus lipase induced by SDS.

Fano M, van de Weert M, Moeller EH, Kruse NA, Frokjaer S.

Arch Biochem Biophys. 2011 Feb 1;506(1):92-8. doi: 10.1016/j.abb.2010.11.012. Epub 2010 Nov 17.

PMID:
21093408
20.

Ghrelin-liposome interactions: characterization of liposomal formulations of an acylated 28-amino acid peptide using CE.

Østergaard J, Moeller EH.

Electrophoresis. 2010 Jan;31(2):339-45. doi: 10.1002/elps.200900394.

PMID:
20024925

Supplemental Content

Loading ...
Support Center